• Je něco špatně v tomto záznamu ?

The origin, in vitro differentiation, and stemness specificity of progenitor cells

W. Kranc, J. Budna, M. Dudek, A. Bryja, A. Chachuła, S. Ciesiółka, S. Borys, M. Dyszkiewicz-Konwińska, M. Jeseta, L. Porowski, P. Antosik, D. Bukowska, KP. Brüssow, M. Bruska, M. Nowicki, M. Zabel, B. Kempisty,

. 2017 ; 31 (2) : 365-369.

Jazyk angličtina Země Itálie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17030701

Since the successful collection of the first progenitor stem cells (SCs), there has been an increased interest in these cells as a model for undiscovered and unlimited potential of differentiation and development. Additionally, it was shown that SC populations display an ability to form pluripotent and/or totipotent cell populations. It was found that human ovarian granulosa cells (GCs) maintain a large capacity for differentiation into several other cell lineages, such as chondrogenic, osteogenic, neurogenic, and adipogenic, particularly during long-term, in vitro culture. In these cases, the specific media supplements that promote various pathways of differentiation, such as leukemia-inhibiting factor (LIF) and/or FSH, are well recognized. However, these are only some examples of the differentiation possibilities of human SCs in vitro and other pathways still require further investigation. Many SC populations, which are directed to differentiate into specific cell types, are also successfully used in several human disease therapies, e.g. leukemia. Moreover, SCs are used for tissue scaffold construction in patients with respiratory and cardiovascular diseases. In this review, the most recent knowledge about the in vitro growth and differentiation capacity of SCs is presented. Furthermore, we discuss the possible worldwide application of SCs in advanced cell and tissue bioengineering. In conclusion, it is suggested that, in the future, SCs will be a basic strategy in human therapy, and their use will open new gates in regenerative and reconstructive medicine in the 21st century.

000      
00000naa a2200000 a 4500
001      
bmc17030701
003      
CZ-PrNML
005      
20171102123022.0
007      
ta
008      
171025s2017 it f 000 0|eng||
009      
AR
035    __
$a (PubMed)28685538
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a it
100    1_
$a Kranc, W $u Department of Anatomy, Poznan University of Medical Sciences, Poznan, Poland.
245    14
$a The origin, in vitro differentiation, and stemness specificity of progenitor cells / $c W. Kranc, J. Budna, M. Dudek, A. Bryja, A. Chachuła, S. Ciesiółka, S. Borys, M. Dyszkiewicz-Konwińska, M. Jeseta, L. Porowski, P. Antosik, D. Bukowska, KP. Brüssow, M. Bruska, M. Nowicki, M. Zabel, B. Kempisty,
520    9_
$a Since the successful collection of the first progenitor stem cells (SCs), there has been an increased interest in these cells as a model for undiscovered and unlimited potential of differentiation and development. Additionally, it was shown that SC populations display an ability to form pluripotent and/or totipotent cell populations. It was found that human ovarian granulosa cells (GCs) maintain a large capacity for differentiation into several other cell lineages, such as chondrogenic, osteogenic, neurogenic, and adipogenic, particularly during long-term, in vitro culture. In these cases, the specific media supplements that promote various pathways of differentiation, such as leukemia-inhibiting factor (LIF) and/or FSH, are well recognized. However, these are only some examples of the differentiation possibilities of human SCs in vitro and other pathways still require further investigation. Many SC populations, which are directed to differentiate into specific cell types, are also successfully used in several human disease therapies, e.g. leukemia. Moreover, SCs are used for tissue scaffold construction in patients with respiratory and cardiovascular diseases. In this review, the most recent knowledge about the in vitro growth and differentiation capacity of SCs is presented. Furthermore, we discuss the possible worldwide application of SCs in advanced cell and tissue bioengineering. In conclusion, it is suggested that, in the future, SCs will be a basic strategy in human therapy, and their use will open new gates in regenerative and reconstructive medicine in the 21st century.
650    _2
$a zvířata $7 D000818
650    _2
$a buněčná diferenciace $x fyziologie $7 D002454
650    _2
$a buněčná a tkáňová terapie $x metody $x trendy $7 D064987
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a folikulární buňky $x cytologie $x fyziologie $7 D006107
650    _2
$a lidé $7 D006801
650    _2
$a leukemický inhibiční faktor $x metabolismus $7 D053605
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a kmenové buňky $x cytologie $x fyziologie $7 D013234
655    _2
$a časopisecké články $7 D016428
700    1_
$a Budna, J $u Department of Histology and Embryology, Poznan University of Medical Sciences, Poznan, Poland.
700    1_
$a Dudek, M $u Department of Anatomy, Poznan University of Medical Sciences, Poznan, Poland.
700    1_
$a Bryja, A $u Department of Anatomy, Poznan University of Medical Sciences, Poznan, Poland.
700    1_
$a Chachuła, A $u Department of Histology and Embryology, Poznan University of Medical Sciences, Poznan, Poland.
700    1_
$a Ciesiółka, S $u Department of Histology and Embryology, Poznan University of Medical Sciences, Poznan, Poland.
700    1_
$a Borys, S $u Department of Anatomy, Poznan University of Medical Sciences, Poznan, Poland.
700    1_
$a Dyszkiewicz-Konwińska, M $u Department of Biomaterials and Experimental Dentistry, Poznan University of Medical Sciences, Poznan, Poland.
700    1_
$a Jeseta, M $u Department of Obstetrics and Gynecology, University Hospital and Masaryk University, Brno, Czech Republic.
700    1_
$a Porowski, L $u Department of Anatomy, Poznan University of Medical Sciences, Poznan, Poland.
700    1_
$a Antosik, P $u Institute of Veterinary Sciences, Poznan University of Life Sciences, Poznan, Poland. $7 gn_A_00007535
700    1_
$a Bukowska, D $u Institute of Veterinary Sciences, Poznan University of Life Sciences, Poznan, Poland.
700    1_
$a Brüssow, K P $u Department of Anatomy, Poznan University of Medical Sciences, Poznan, Poland.
700    1_
$a Bruska, M $u Department of Anatomy, Poznan University of Medical Sciences, Poznan, Poland.
700    1_
$a Nowicki, M $u Department of Histology and Embryology, Poznan University of Medical Sciences, Poznan, Poland.
700    1_
$a Zabel, M $u Department of Histology and Embryology, Poznan University of Medical Sciences, Poznan, Poland. Department of Histology and Embryology, Wroclaw Medical University, Wroclaw, Poland.
700    1_
$a Kempisty, B $u Department of Anatomy, Poznan University of Medical Sciences, Poznan, Poland. Department of Histology and Embryology, Poznan University of Medical Sciences, Poznan, Poland.
773    0_
$w MED00008336 $t Journal of biological regulators and homeostatic agents $x 0393-974X $g Roč. 31, č. 2 (2017), s. 365-369
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28685538 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20171025 $b ABA008
991    __
$a 20171102123115 $b ABA008
999    __
$a ok $b bmc $g 1254294 $s 991728
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 31 $c 2 $d 365-369 $i 0393-974X $m Journal of Biological Regulators & Homeostatic Agents $n J Biol Regul Homeost Agents $x MED00008336
LZP    __
$a Pubmed-20171025

Najít záznam

Citační ukazatele

Možnosti archivace